Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
RepligenRGEN | Open-market sale10b5-1 plan | 09/24 | 09/25 | 12,946 sh2 trades | $190.00avg. | $2,459,740 | −21.1% | |
RepligenRGEN | Open-market sale10b5-1 plan | 06/25 | 06/26 | 733 sh | $145.00 | $106,285 | −3.6% | |
RepligenRGEN | Open-market sale10b5-1 plan | 04/21 | 04/22 | 3,832 sh | $140.00 | $536,480 | −6.6% | |
Karen A. DawesDirector | RepligenRGEN | Open-market sale | 25/12/17 | 25/12/18 | 275 sh | $161.00 | $44,275 | −0.3% |
RepligenRGEN | Open-market sale10b5-1 plan | 25/11/25 | 25/11/26 | 7,041 sh | $170.00 | $1,196,970 | −16.4% | |
James BylundCOO | RepligenRGEN | Open-market sale | 25/11/18 | 25/11/19 | 2,191 sh | $151.21 | $331,301.11 | −9.2% |
RepligenRGEN | Open-market sale | 25/11/13 | 25/11/14 | 20,000 sh7 trades | $154.61avg. | $3,092,278.36 | −19.9% | |
RepligenRGEN | Open-market sale10b5-1 plan | 25/11/12 | 25/11/13 | 25,000 sh5 trades | $156.88avg. | $3,921,939.67 | −19.9% | |
RepligenRGEN | Open-market sale | 25/09/10 | 25/09/11 | 29,111 sh6 trades | $120.52avg. | $3,508,388.91 | −22.4% | |
Martin D. MadausDirector | RepligenRGEN | Open-market buy | 25/08/08 | 25/08/12 | 1,800 sh | $112.13 | $201,834 | No record |
RepligenRGEN | Open-market sale10b5-1 plan | 25/05/15 | 25/05/16 | 26,447 sh5 trades | $123.71avg. | $3,271,687.92 | −19.4% | |
RepligenRGEN | Open-market sale10b5-1 plan | 25/03/17 | 25/03/19 | 26,756 sh6 trades | $152.51avg. | $4,080,663.26 | −16.4% | |
Margaret PaxDirector | RepligenRGEN | Open-market buy | 25/03/17 | 25/03/18 | 250 sh | $150.69 | $37,672.5 | +31.5% |
Anthony HuntDirector | RepligenRGEN | Open-market sale | 24/11/21 | 24/11/22 | 24,246 sh | $139.67 | $3,386,438.82 | −14.8% |
RepligenRGEN | Open-market sale10b5-1 plan | 24/09/10 | 24/09/12 | 22,191 sh4 trades | $145.37avg. | $3,225,927.4 | −13.7% | |
RepligenRGEN | Open-market sale | 24/08/02 | 24/08/05 | 7,148 sh2 trades | $159.35avg. | $1,139,016.03 | −36.8% | |
Ralf KuriyelSenior VP, R&D | RepligenRGEN | Open-market sale | 24/08/01 | 24/08/01 | 4,465 sh | $165.67 | $739,716.55 | −18.8% |
Nicolas BarthelemyDirector | RepligenRGEN | Open-market buy | 24/06/14 | 24/06/14 | 1,200 sh | $125.45 | $150,540 | +34.6% |
RepligenRGEN | Open-market buy | 24/06/14 | 24/06/14 | 1,615 sh2 trades | $124.94avg. | $201,776.1 | +53.9% | |
Anthony HuntCEO | RepligenRGEN | Open-market buy | 24/06/14 | 24/06/14 | 2,000 sh | $124.08 | $248,160 | +1.2% |
